Biswajit Mahapatra

Dr. Biswajit Mahapatra

Anthropology, Anthropological Survey of India, Kolkata, India
orcid
Anthropologist at the Anthropological Survey of India, Minis...

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Journal of Family Medicine and Primary Care
Verified
Journal Article
Open access
Biswajit MahapatraBiswajit Mahapatra
Biswajit Mahapatra
NMNirmalya Mukherjee
Nirmalya Mukherjee
SKSajda Khatoon
Sajda Khatoon
PBParamita Bhattacharya
Paramita Bhattacharya
DJDenny John
Denny John
Background: Tribes are the most socially excluded group in the nation due to their restricted access to healthcare. There are little data on the real burden and distribution of illnesses among tribes. The present study determines the types and patterns of sickness among tribal populations in West Bengal. Methods: Five blocks from five districts in West Bengal were used for this cross-sectional study. Between the years 2018 and 2019, 52,189 patients visited these mobile medical clinics (MMCs), but only 36,128 were included in our study. Data were analyzed using the SPSS software (ver. 27.0). Results: Younger age groups (1-25 years) show higher primary registration compared to other age categories; older age groups (>60 years) show higher repeat registration. High prevalence in infectious diseases (44.5% of the total primary registration) and high repeated cases in NCDs (11.5% to 33.2%), which are nearly three times higher than primary cases (Cramer’s V test = 0.29; P = .001) are observed. Among the studied MMCs, Binpur II and Matiali MMC have more than two times the risk of gastrointestinal problems, while Madarihat MMC has more than one time the risk. Garbeta II MMC shows more than three times the risk of NCDs (adjusted odds ratio = 3.97; 95% confidence interval: 3.05-5.17) than the other diseases. Conclusion: The present study shows high prevalence of infectious diseases, injury and pain, NCDs, gastrointestinal problems, and vertigo in tribal populations of West Bengal.


11 March 2024 in JBI Evidence Synthesis
Verified
Journal Article
Closed access
Biswajit MahapatraBiswajit Mahapatra
Biswajit Mahapatra
NMNirmalya Mukherjee
Nirmalya Mukherjee
SKSajda Khatoon
Sajda Khatoon
PBParamita Bhattacharya
Paramita Bhattacharya
PDPritha Das
Pritha Das
Denny JohnDenny John
Denny John
Objective: The objective of this systematic review is to provide an overview of economic evaluation studies of interventions for neglected tropical diseases in low- and/or middle-income countries. Introduction: The majority of people most susceptible to neglected tropical diseases reside in low- and middle-income countries and suffer significant economic impact due to these diseases. The World Health Organization suggests utilizing a systematic and cross-cutting approach with multiple interventions to lessen the neglected tropical disease burden. Inclusion criteria: Studies will be eligible for inclusion if they include economic evaluations of interventions for neglected tropical diseases and are conducted in low- and/or middle-income country settings. Methods: A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as neglected tropical disease, economic evaluation, therapeutics, low- and/or middle-income countries. Two reviewers will screen titles and abstracts independently, followed by a full-text review against the inclusion criteria. Disagreements will be resolved by discussion or with a third reviewer. To assess methodological quality, the JBI checklist for economic evaluations will be used. For economic evaluations, data will be extracted using the standardized JBI data extraction form. The Dominance Ranking Matrix will be used to summarize and compare the results of different types of economic evaluations. Cost per quality adjusted life year gained and cost per disability adjusted life year averted will be measures for economic evaluation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to assess the certainty of economic evidence, such as resource use and costs. Review registration: PROSPERO CRD42017070386

17 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
SKSajda Khatoon
Sajda Khatoon
PBParamita Bhattacharya
Paramita Bhattacharya
VKVineetha Karuveettil
Vineetha Karuveettil
Biswajit MahapatraBiswajit Mahapatra
Biswajit Mahapatra
SMSupriya Mathew
Supriya Mathew
Denny JohnDenny John
Denny John
Objective The objective of this review is to provide consolidated evidence on the occurrence of vector-borne diseases is associated with climate change in South Asia. Introduction: Vector Borne Diseases (VBDs) are parasitic, viral, and bacterial ailments transmitted to humans by vectors. Vectors are organisms capable of transmitting infectious pathogens between humans or between humans and animals. Vector Borne Diseases (VBDs) are one of the climate-sensitive communicable diseases identified by the Intergovernmental Panel on Climate Change. Climate change is a cause for concern since it can have direct and indirect effects on the epidemiology of VBDs. South Asian countries are highly vulnerable to climate change according to the ND-GAIN Country Index. Inclusion criteria: This systematic review will include the studies on the population residing in eight South Asian countries of India, Pakistan, Bangladesh, Sri Lanka, Bhutan, Nepal, Maldives and Afghanistan related to vector borne diseases; namely, malaria, dengue, chikungunya, Japanese encephalitis, lymphatic filariasis, Leishmaniasis or kala-azar and schistosomiasis in South Asia and their association with climate change aspects such as increased temperatures, varied precipitation, humidity levels as outcomes. Methods A preliminary search of PubMed will be conducted using MESH terms to find relevant papers on Vector Borne Disease, climate change, South Asia. A three-step search approach will be then implemented, including a preliminary limited search, using textual terms in titles and abstracts, and index terms. The databases to be searched for published papers will include Embase (Elsevier), MEDLINE (PubMed), Scopus (Elsevier), Web of Science (Clarivate), and Google Scholar. Grey literature, such as Ministry of Health and Family Welfare's technical reports, master's and doctoral dissertations, technical reports of WHO, World Bank, Asian Development Bank, and other grey literature will be searched and analyzed. Titles and abstracts will be screened by two independent reviewers, and papers selected for retrieval will be evaluated for methodological validity using standard checklists. Data will be extracted and synthesized using JBI data extraction forms and synthesis tools for risk/etiology. A meta-analysis of quantitative data will, where possible will be performed using R Studio, and where meta-analysis is not possible, the results will be provided in narrative format including tables and figures to aid in data presentation.

28 September 2023 in JBI Evidence Synthesis
Verified
Journal Article
Closed access
Biswajit MahapatraBiswajit Mahapatra
Biswajit Mahapatra
PBParamita Bhattacharya
Paramita Bhattacharya
VKVineetha Karuveettil
Vineetha Karuveettil
DJDenny John
Denny John
SKSajda Khatoon
Sajda Khatoon
CJChandrashekar Jankiram
Chandrashekar Jankiram
Objective: The purpose of this systematic review is to assess the available economic evidence of a decentralized care model compared to a centralized model for treating multi-drug-resistant tuberculosis (MDR-TB) in low- and middle-income countries (LMICs). Introduction: Diseases that affect physiological health create a burden on human livelihoods and the economy. There is a lack of studies examining the economic evaluation of MDR-TB across different countries. A preliminary search identified no published or ongoing reviews on MDR-TB in LMICs. Inclusion criteria: Studies will be eligible if they include both patients receiving centralized care (ie, care provided by specialist centers through inpatient or outpatient services) and patients receiving decentralized care (ie, care provided by grassroots community workers in peripheral facilities or in the patients' residence) for MDR-TB in LMICs. Eligible studies will report economic evaluations of treatment for MDR-TB. Methods: A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as MDR-TB, economic evaluation, therapeutics, LMICs. Two reviewers will independently screen the titles, abstracts, and full text against the inclusion criteria. Disagreements will be resolved through discussion or with a third reviewer. The JBI checklist for economic evaluations will be utilized to evaluate the methodological quality. Data will be extracted using a modified JBI data extraction form for economic evaluations. The Dominance Ranking Matrix, developed by JBI for economic evaluations, will be used to summarize and compare the results of different types of economic evaluations (cost-effectiveness, cost-benefit analysis, cost-utility analysis, or cost-minimization analysis). Cost per quality-adjusted life year gained and cost per disability-adjusted life year averted will be measures for economic evaluation. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach will be used to assess the certainty of economic evidence. Review registration: PROSPERO CRD42022368696

17 July 2020 in Journal of Medical Science And clinical Research
Verified
Journal Article
Closed access
Biswajit MahapatraBiswajit Mahapatra
Biswajit Mahapatra